Newtyn Management, LLC Merrimack Pharmaceuticals Inc Transaction History

Newtyn Management, LLC

$464 Million
Q1 2024

A detailed history of Newtyn Management, LLC transactions in Merrimack Pharmaceuticals Inc stock. As of the latest transaction made, Newtyn Management, LLC holds 1,873,694 shares of MACK stock, worth $28.3 Million. This represents 5.97% of its overall portfolio holdings.

Number of Shares

1,873,694

Previous 1,873,694 -0.0%

Holding current value

$28.3 Million

Previous $25.1 Million 10.14%

% of portfolio

5.97%

Previous 5.31%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$11.35 - $12.32 $1.2 Million - $1.3 Million	105,300 Added 5.95%	1,873,694 $23 Million
Q4 2022 Feb 14, 2023	BUY	$3.68 - $12.51 $4,784 - $16,263	1,300 Added 0.07%	1,768,394 $20.3 Million
Q3 2022 Nov 14, 2022	BUY	$3.7 - $6.06 $33,629 - $55,079	9,089 Added 0.52%	1,767,094 $6.63 Million
Q2 2022 Aug 15, 2022	BUY	$4.89 - $7.13 $217,081 - $316,522	44,393 Added 2.59%	1,758,005 $10.5 Million
Q1 2022 May 16, 2022	BUY	$3.75 - $6.82 $617,733 - $1.12 Million	164,729 Added 10.64%	1,713,612 $10.8 Million

Q4 2020 Feb 16, 2021	BUY	$3.69 - $8.31 $931,529 - $2.1 Million	252,447 Added 19.47%	1,548,883 $10.7 Million
Q3 2020 Nov 16, 2020	BUY	$3.1 - $4.3 $300,173 - $416,369	96,830 Added 8.07%	1,296,436 $5.19 Million
Q2 2020 Aug 14, 2020	BUY	$2.21 - $3.88 $58,432 - $102,587	26,440 Added 2.25%	1,199,606 $4 Million
Q3 2019 Nov 14, 2019	SELL	$4.16 - $6.05 $162,148 - $235,816	-38,978 Reduced 3.22%	1,173,166 $5.27 Million
Q2 2019 Aug 14, 2019	BUY	$4.39 - $5.66 $296,592 - $382,395	67,561 Added 5.9%	1,212,144 $7.33 Million
Q1 2019 May 15, 2019	BUY	$3.19 - $5.73 $816,521 - $1.47 Million	255,963 Added 28.8%	1,144,583 $7.96 Million
Q4 2018 Feb 14, 2019	BUY	$2.95 - $4.15 $630,179 - $886,523	213,620 Added 31.65%	888,620 $3.43 Million
Q3 2018 Nov 14, 2018	BUY	$3.91 - $4.66 $163,058 - $194,335	41,703 Added 6.59%	675,000 $3.6 Million
Q2 2018 Aug 14, 2018	BUY	$3.86 - $7.61 $1.9 Million - $3.75 Million	492,440 Added 349.6%	633,297 $3.11 Million
Q1 2018 May 15, 2018	SELL	$6.24 - $9.15 $1.38 Million - $2.03 Million	-221,478 Reduced 61.13%	140,857 $1.13 Million
Q4 2017 Feb 14, 2018	SELL	$7.99 - $11.87 $221,043 - $328,383	-27,665 Reduced 7.09%	362,335 $3.71 Million
Q3 2017 Nov 14, 2017	BUY	$9.13 - $11.72 $3.56 Million - $4.57 Million	390,000	390,000 $5.67 Million

Others Institutions Holding MACK

# of Institutions

Shares Held

9.18M

Call Options Held

64K

Put Options Held

3.2K

View Full List

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Newtyn Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Newtyn Management, LLC with notifications on news.

Account

Newtyn Management, LLC Merrimack Pharmaceuticals Inc Transaction History